Skip to content

COMPARISON OF SYSTEMIC INFLAMMATION-RELATED HEMATOLOGICAL PARAMETERS IN ACUTE AND CHRONIC LOW BACK PAIN

COMPARISON OF SYSTEMIC INFLAMMATION-RELATED HEMATOLOGICAL PARAMETERS IN ACUTE AND CHRONIC LOW BACK PAIN

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04897620
Enrollment
450
Registered
2021-05-21
Start date
2021-05-05
Completion date
2021-06-05
Last updated
2021-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Chronic

Brief summary

The aim of the study is to compare the neutrophils to lymphocytes ratio (NLR), platelets to lymphocytes ratio (PLR), eosinophils to lymphocytes ratio (ELR), red blood cell distribution width (RDW), mean platelet volume (MPV), systemic immune inflammation index (SII), erythrocyte sedimentation rate (ESR) and C reactive protein (CRP) which are the hematological parameters associated with systemic inflammation in acute and subacute/chronic low back pain. Secondary purpose; evaluation of the prognostic roles of hematological parameters associated with systemic inflammation in low back pain in predicting chronicity.This study is a retrospective case-control study. The data of patients who applied to the emergency department with the complaint of acute (less than 4 weeks) low back pain or to the Physical Medicine and Rehabilitation outpatient clinic with the complaint of subacute (lasting 4-12 weeks) or chronic (longer than 12 weeks) non-specific low back pain in the last 3 years will be scanned. The data of patients who applied with complaints other than medical conditions known to be associated with painful conditions and/or inflammatory response will be screened as a control group. The data of patients between the ages of 18-65 will be included in the study. In conclusion, the data of 150 patients who presented with acute non-specific low back pain, 150 patients who presented with subacute/chronic non-specific low back pain and 150 participants as the control group will be included in the study for use in analysis. Participants' age, gender, duration of low back pain (days), if evaluated, conditions associated with low back pain in cases with subacute/chronic pain, ESR, CRP, RDW, MPV, neutrophil count, lymphocyte count, eosinophil count and platelet count in blood tests at admission examinations will be recorded. NLR will be calculated by dividing the number of neutrophils by the number of lymphocytes, PLR by dividing the number of platelets by the number of lymphocytes, ELR by dividing the number of eosinophils by the number of lymphocytes, and SII by the formula platelet numberxneutrophil number/lymphocyte number.

Interventions

OTHERScanning the blood test results

Participants' age, gender, duration of low back pain (days), if evaluated, conditions associated with low back pain in cases with subacute/chronic pain, ESR, CRP, RDW, MPV, neutrophil count, lymphocyte count, eosinophil count and platelet count in blood tests at admission examinations were recorded. NLR was calculated by dividing the number of neutrophils by the number of lymphocytes, PLR by dividing the number of platelets by the number of lymphocytes, ELR by dividing the number of eosinophils by the number of lymphocytes, and SII by the formula platelet numberxneutrophil number/lymphocyte number

Sponsors

Ufuk University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

* The data of patients who applied to the emergency department with the complaint of acute (less than 4 weeks) low back pain or to the Physical Medicine and Rehabilitation outpatient clinic with the complaint of subacute (lasting 4-12 weeks) or chronic (longer than 12 weeks) non-specific low back pain in the last 3 years. * The data of patients between the ages of 18-65.

Exclusion criteria

* Patients who have systemic diseases or internal organ pathologies that may cause low back pain, acute/chronic infection, malignancy, rheumatic disease or systemic diseases that may change the hematological inflammation parameters, which are evaluation parameters, * Patients who have severe neurological involvement findings in imaging examinations or clinical examination, * Patients who have a history of surgical procedures for the lumbar region in the last 6 months * Patients those missing one or more of the parameters planned to be evaluated within the scope of the screened data.

Design outcomes

Primary

MeasureTime frameDescription
Erythrocyte sedimentation rate1 monthThe erythrocyte sedimentation rate value in blood tests at admission examinations.
C reactive protein1 monthThe C reactive protein value in blood tests at admission examinations.
Red blood cell distribution width1 monthThe red blood cell distribution width value in blood tests at admission examinations.
Mean platelet volume1 monthThe mean platelet volume value in blood tests at admission examinations.
Neutrophils to lymphocytes ratio (NLR)1 monthNLR is calculated by dividing the number of neutrophils by the number of lymphocytes.
Platelets to lymphocytes ratio (PLR)1 monthPLR is calculated by dividing the number of platelets by the number of lymphocytes.
Eosinophils to lymphocytes ratio (ELR)1 monthELR is calculated by dividing the number of eosinophils by the number of lymphocytes.
Systemic immune inflammation index (SII)1 monthSII is calculated by the formula platelet numberxneutrophil number/lymphocyte number.

Countries

Turkey (Türkiye)

Contacts

Primary ContactElzem Bolkan Günaydın
elzembolkan@yahoo.com05309787303

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026